tykhr
sign in
free sign up
Bellicum Pharmaceuticals Inc
Biotechnology
Healthcare
BLCM
30.83 M shares
NASDAQ US
traded
08 Feb 2023
listed
yes
open
1.36
52 week high
3.65
high
1.43
52 week low
1.32
low
1.31
growth
-20.23 %
previous Close
1.36
P/E ratio
market cap
12.57 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
-4.00 M
47.09 %
eps
0.00 %
48.00 %
eps surprise
81.16 %
net profit margin
-400100000.00 %
0.00 %
operating incoming
-6.54 M
-10.07 %
net change in cash
-6.60 M
-3.32 %
cash on hand
33.17 M
-16.60 %
cost of revenue
0.00 %
top